Scott M Lippman

Scott M Lippman

UNVERIFIED PROFILE

Are you Scott M Lippman?   Register this Author

Register author
Scott M Lippman

Scott M Lippman

Publications by authors named "Scott M Lippman"

Are you Scott M Lippman?   Register this Author

100Publications

3425Reads

43Profile Views

Targeting mTOR in Head and Neck Cancer-Response.

Clin Cancer Res 2019 Nov;25(21):6555

NCI, Potomac, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-2002DOI Listing
November 2019

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics.

Mol Cancer Ther 2019 Oct 18;18(10):1852-1862. Epub 2019 Jul 18.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0965DOI Listing
October 2019

Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy.

Cancer Immunol Res 2019 Oct 12;7(10):1570-1573. Epub 2019 Aug 12.

University of California San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-19-0149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774837PMC
October 2019

A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors Following Curative-Intent Treatment.

Am J Phys Med Rehabil 2019 Jul 26. Epub 2019 Jul 26.

Gastrointestinal and Palliative Radiation Oncology Department of Radiation Medicine and Applied Sciences University of California, San Diego.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PHM.0000000000001281DOI Listing
July 2019

Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer.

Pancreas 2018 Nov/Dec;47(10):1175-1176

Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000001165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193263PMC
March 2019

Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer.

Cancer Res 2019 02 4;79(4):689-698. Epub 2019 Feb 4.

University of California San Diego, Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-1281DOI Listing
February 2019

Waun Ki Hong (1942-2019) John Mendelsohn (1936-2019).

Cancer Cell 2019 Feb 11;35(2):157-160. Epub 2019 Feb 11.

Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108193004
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2019.01.014DOI Listing
February 2019

Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival.

JCO Precis Oncol 2019 25;3. Epub 2019 Jan 25.

Shumei Kato, Maria C. Schwaederlé, Paul T. Fanta, Ryosuke Okamura, Lawrence Leichman, and Scott M. Lippman, Razelle Kurzrock, University of California San Diego Moores Cancer Center, La Jolla; and Richard B. Lanman, Victoria M. Raymond, and AmirAli Talasaz, Guardant Health, Redwood City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.18.00158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484865PMC
January 2019

Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.

Clin Cancer Res 2018 12 22;24(24):6248-6256. Epub 2018 Oct 22.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-1128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384095PMC
December 2018

Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer.

Support Care Cancer 2018 Jul 10;26(7):2459-2469. Epub 2018 Feb 10.

Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, 9300 Campus Point Drive, MC 7381, La Jolla, CA, 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4078-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110278PMC
July 2018

Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients.

Sci Rep 2018 Jul 13;8(1):10640. Epub 2018 Jul 13.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41598-018-25712-1
Publisher Site
http://dx.doi.org/10.1038/s41598-018-25712-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045646PMC
July 2018

Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer.

J Oncol Pharm Pract 2018 04 12;24(3):229-231. Epub 2017 Mar 12.

1 Lucy Curci Cancer Center, Eisenhower Medical Center, Rancho Mirage, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217698845DOI Listing
April 2018

Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma.

Eur J Cancer 2018 03 3;92:20-32. Epub 2018 Feb 3.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.023DOI Listing
March 2018

Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer.

J Oncol Pharm Pract 2017 Dec 18;23(8):638-640. Epub 2016 Oct 18.

1 Lucy Curci Cancer Center, Eisenhower Medical Center, Rancho Mirage, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155216674355DOI Listing
December 2017

Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary.

Cancer Res 2017 08 22;77(16):4238-4246. Epub 2017 Jun 22.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-0628DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729906PMC
August 2017

Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence.

Lancet Oncol 2017 08 26;18(8):e457-e471. Epub 2017 Jul 26.

Moores Cancer Center, University of California, La Jolla, San Diego, CA, USA; Department of Medicine, University of California, La Jolla, San Diego, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30411-4DOI Listing
August 2017

Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.

Oral Oncol 2017 02 31;65:68-75. Epub 2016 Dec 31.

Department of Otolaryngology-Head and Neck Surgery, University of California, San Diego, La Jolla, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2016.12.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291169PMC
February 2017

Translating Germline Cancer Risk into Precision Prevention.

Cell 2017 02;168(4):566-570

Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2017.01.031DOI Listing
February 2017

Sleep and Breathing … and Cancer?

Cancer Prev Res (Phila) 2016 11 7;9(11):821-827. Epub 2016 Sep 7.

Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-16-0092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353979PMC
November 2016

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize.

Nat Commun 2016 10 4;7:13019. Epub 2016 Oct 4.

Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms13019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059467PMC
October 2016

Leveraging premalignant biology for immune-based cancer prevention.

Proc Natl Acad Sci U S A 2016 09 16;113(39):10750-8. Epub 2016 Sep 16.

Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA 92093;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047191PMC
http://dx.doi.org/10.1073/pnas.1608077113DOI Listing
September 2016

The Conundrum of Genetic "Drivers" in Benign Conditions.

J Natl Cancer Inst 2016 08 7;108(8). Epub 2016 Apr 7.

Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, TX (SK); Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UC San Diego Moores Cancer Center, La Jolla, CA (SML, RK); Henri and Belinda Termeer Center for Targeted Therapies, Massachusetts General Hospital Cancer Center, Boston, MA (KTF).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017937PMC
August 2016

Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress.

Free Radic Biol Med 2016 06 22;95:349-56. Epub 2016 Mar 22.

Division of Nutritional Sciences, Cornell University, 209 Savage Hall, Ithaca, NY 14853, USA; Department of Healthcare Policy and Research, Division of Biostatistics and Epidemiology, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2016.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867301PMC
June 2016

Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience.

Mol Cancer Ther 2016 04 12;15(4):743-52. Epub 2016 Feb 12.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, California.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-15
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-15-0795DOI Listing
April 2016

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial.

Cancer Epidemiol Biomarkers Prev 2016 Mar 29;25(3):463-9. Epub 2015 Dec 29.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Department of Urology and the James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0987DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779655PMC
March 2016

Cancer Prevention: Obstacles, Challenges and the Road Ahead.

J Natl Cancer Inst 2016 Feb 7;108(2). Epub 2015 Nov 7.

Biological Chemistry, Public Health, and Epidemiology, Chao Family Comprehensive Cancer Center, School of Medicine - University of California, Irvine, Irvine, CA (FLMJr); Arizona Board of Regents Professor of Medicine, Pharmacology, Public Health, Nutritional Sciences & BIO5, University of Arizona Cancer Center, Skin Cancer Institute, Tucson, AZ (DSA); Wolfson Institute of Preventive Medicine and Head, Centre for Cancer Prevention; Centre for Cancer Prevention, Queen Mary University of London, Mile End Road, London, UK (JC); Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA (TWK); Moores Cancer Center (SML) and Department of Family Medicine and Public Health, Cancer Prevention and Control Program (CLR), UC San Diego, San Diego, CA (SML); Dermatology Research Laboratories, University of Wisconsin; Madison, WI (HM); Hutchinson Institute for Cancer Outcomes Research, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA (SDR); Center for Cancer Prevention Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ (CSY).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907357PMC
February 2016

Catalyzing Cancer Prevention Research CaPR: A New Year/New Opportunities.

Authors:
Scott M Lippman

Cancer Prev Res (Phila) 2016 Jan;9(1)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0430DOI Listing
January 2016

New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.

Cancer Prev Res (Phila) 2015 Nov 4;8(11):1027-35. Epub 2015 Sep 4.

Cancer Research Center of Lyon, UMR INSERM 1052-CNRS 5286, Lyon, France. Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France. Department of Medicine, Centre Léon Bérard, Lyon, France. Université de Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777304PMC
November 2015

Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.

Cancer Epidemiol Biomarkers Prev 2015 Oct 12;24(10):1507-15. Epub 2015 Aug 12.

Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592455PMC
October 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.

Cancer Prev Res (Phila) 2015 Jul 29;8(7):590-6. Epub 2015 Apr 29.

Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland. James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0398DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491033PMC
July 2015

Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.

Oncotarget 2015 Jun;6(18):16746-56

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599304PMC
http://dx.doi.org/10.18632/oncotarget.3796DOI Listing
June 2015

Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.

Oral Oncol 2015 May 27;51(5):470-5. Epub 2015 Feb 27.

Division of Head and Neck Surgery, University of California, San Diego, CA, USA; Department of Pharmacology, University of California, San Diego, CA, USA; Moores Cancer Center, San Diego, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.01.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427339PMC
May 2015

Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study.

J Thorac Oncol 2015 Feb;10(2):302-8

Departments of *Thoracic and Head and Neck Medical Oncology, ‡Epidemiology, §Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; †Department of Medicine/James P. Wilmot Cancer Center, University of Rochester, Rochester, New York; and ║Moores Cancer Center, University of California, San Diego, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000398DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305022PMC
February 2015

Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.

Clin Cancer Res 2014 Dec 14;20(24):6570-81. Epub 2014 Oct 14.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268116PMC
December 2014

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.

Nat Genet 2014 Sep 3;46(9):939-43. Epub 2014 Aug 3.

1] Bioinformatics and Systems Biology Program, University of California, San Diego, La Jolla, California, USA. [2] Department of Medicine, University of California, San Diego, La Jolla, California, USA. [3] Department of Computer Science and Engineering, University of California, San Diego, La Jolla, California, USA. [4] Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146706PMC
September 2014

Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study.

Carcinogenesis 2014 Aug 17;35(8):1760-4. Epub 2014 Apr 17.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123647PMC
August 2014

Molecular tumor board: the University of California-San Diego Moores Cancer Center experience.

Oncologist 2014 Jun 5;19(6):631-6. Epub 2014 May 5.

Center for Personalized Cancer Therapy, Moores Cancer Center, Division of Hematology-Oncology, Department of Medicine, Department of Radiology, School of Medicine, Department of Pathology, School of Medicine, and Division of Endocrinology & Metabolism, Department of Medicine, University of California San Diego, La Jolla, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041669PMC
June 2014

Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.

Clin Lung Cancer 2014 May 1;15(3):213-21. Epub 2014 Jan 1.

Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; College of Pharmacy, Seoul National University, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304130026
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2013.12.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572464PMC
May 2014

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Cancer Epidemiol Biomarkers Prev 2014 May 18;23(5):847-56. Epub 2014 Apr 18.

Authors' Affiliations: Departments of Pathology and Immunology; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, NIH, Bethesda, Maryland; University of Colorado School of Medicine, Aurora, Colorado; Department of Urology, University of Texas Health Sciences Center San Antonio, San Antonio; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; SWOG Statistical Center; Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Moores Cancer Center, University of California San Diego, La Jolla, California; and Division of Public Health Sciences and The Alvin J. Siteman Cancer Center, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012292PMC
May 2014

John A. Milner: in memoriam (1947-2013).

Cancer Prev Res (Phila) 2014 Apr;7(4):373-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0060DOI Listing
April 2014

Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment.

Head Neck 2014 Mar 19;36(3):E25-7. Epub 2013 Oct 19.

Department of Investigational Cancer Therapeutics, (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hed.23429
Publisher Site
http://dx.doi.org/10.1002/hed.23429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893310PMC
March 2014

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.

J Natl Cancer Inst 2014 Mar 22;106(3):djt456. Epub 2014 Feb 22.

Affiliations of authors: Cancer Prevention Program (ARK) and SWOG Statistical Center (AKD, CMT, PJG), Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology (ARK, GEG) and Department of Environmental Health (GEG), University of Washington, Seattle, WA; University of Missouri, Research Reactor Center, Columbia, MO (JSM); Harry S. Truman Memorial Veterans Hospital, Columbia, MO (JSM); Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX (IMT); Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA (FLM); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, HLP); Moores Cancer Center, University of California San Diego, San Diego, CA (SML); Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH (EAK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975165PMC
March 2014

Letter from the Editor.

Authors:
Scott M Lippman

Cancer Prev Res (Phila) 2014 Feb 24;7(2):179-81. Epub 2014 Jan 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-13-0443DOI Listing
February 2014

Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.

Cancer 2013 Dec 16;119(24):4277-83. Epub 2013 Sep 16.

Department of Epidemiology, The University of Texas MD Anderson Center, Houston, Texas; Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan; Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855186PMC
December 2013

Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial.

Clin Cancer Res 2013 Dec 28;19(24):6967-75. Epub 2013 Oct 28.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Biostatistics and Applied Mathematics, Translational Molecular Pathology, Diagnostic Imaging, Diagnostic Radiology, and Bioinformatics and Computational Biology; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; The Hamon Center for Therapeutic Oncology Research and Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Charlotte, North Carolina; Medical Oncology, Yale Cancer Center, New Haven, Connecticut; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario; Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland; UC San Diego Moores Cancer Center, La Jolla, California; and Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905243PMC
December 2013

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

J Clin Oncol 2013 Nov 3;31(33):4179-87. Epub 2013 Sep 3.

Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston; David H. Johnson, University of Texas Southwestern, Dallas, TX; Sandra J. Lee, Dana-Farber Cancer Institute, Boston, MA; Steven M. Keller, Montefiore Medical Center, Bronx, NY; Gail Shaw Wright, Florida Cancer Specialists, New Port Richey, FL; Seena Aisner, University of Medicine and Dentistry of New Jersey/New Jersey Medical School Cancer Institute of New Jersey, Newark, NJ; Steven Alan Belinsky, Lovelace Respiratory Research Institute, Albuquerque, NM; Gary Goodman, Swedish Medical Center Cancer Institute; Gary Goodman, Fred Hutchinson Cancer Research Center, Seattle, WA; Gerald Clamon, University of Iowa, Iowa City, IA; Randolph Marks, Mayo Clinic, Rochester, MN; Worta McCaskill-Stevens, National Cancer Institute, Rockville, MD; Scott M. Lippman, University of California San Diego Cancer Center, San Diego, CA; John Ruckdeschel, Intermountain Healthcare, Salt Lake City, UT; Fadlo R. Khuri, Emory University, Atlanta, GA; Michael R. Johnston, Dalhousie University, Halifax, Nova Scotia; Michael R. Johnston, National Cancer Institute of Canada Clinical Trials Group, Kingston; Gordon Okawara, McMaster University, Hamilton, Ontario; and Eric Frechette, Hopital Laval, Quebec City, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821010PMC
November 2013

Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

J Natl Cancer Inst 2013 Oct 3;105(20):1558-70. Epub 2013 Oct 3.

Affiliations of authors: Department of Thoracic/Head and Neck Medical Oncology (DHS, SPC, FMJ, SML, BSG) and Department of Experimental Therapeutics (KM), The University of Texas MD Anderson Cancer Center, Houston, TX; College of Pharmacy, Inje University, Gimhae, Gyungnam, Republic of Korea (H-JL); College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea (H-YM, M-SL, JWL, H-YL).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797025PMC
October 2013

Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer.

Cancer Res 2013 Aug 17;73(15):4801-9. Epub 2013 Jun 17.

Departments of Epidemiology and Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-3273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760306PMC
August 2013

Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.

J Thorac Oncol 2013 Apr;8(4):436-42

Department of Diagnostic Radiology, Unit 1471, The University of Texas, M.D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318287c91eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879952PMC
April 2013

MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.

Cancer Res 2013 Mar 1;73(6):1867-75. Epub 2013 Feb 1.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-0873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602350PMC
March 2013

Looking forward to 2013--saluting the exceptional year in 2012.

Authors:
Scott M Lippman

Cancer Prev Res (Phila) 2013 Jan;6(1):1-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-12-0469DOI Listing
January 2013